$VTRS Myan wins summary judgment ruling in Kansas EpiPen class action Мьян выиграл суммарное судебное решение по групповому иску Kansas EpiPen Viatris (VTRS) announced that the "U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's (MYL) favor on the company's summary judgment motion in the class action related to EpiPen(R) Auto-Injector. The company is pleased with the court's decision to dismiss all of the plaintiffs' claims under the federal RICO statute, which include claims asserted against Mylan's former CEO Heather Bresch. The court also dismissed claims alleging that Mylan foreclosed branded competition through rebate arrangements with pharmacy benefit managers."